Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Daiichi Sankyo Co Ltd

Start price
Target price
Perf. (%)
€30.99
20.02.24
-
20.02.27
12.91%
16.07.24

robertinio 
20.02.24 100%
sell
Daiichi Sankyo Co Ltd

Start price
Target price
Perf. (%)
€30.99
20.02.24
-
20.02.27
12.91%
16.07.24

robertinio 
20.02.24 100%
sell
Daiichi Sankyo Co Ltd

Start price
Target price
Perf. (%)
€30.99
20.02.24
-
20.02.27
12.91%
16.07.24

robertinio 
20.02.24 100%
sell
Daiichi Sankyo Co Ltd

Start price
Target price
Perf. (%)
€30.99
20.02.24
-
20.02.27
12.91%
16.07.24

robertinio 
20.02.24 100%
sell
Daiichi Sankyo Co Ltd

Start price
Target price
Perf. (%)
€30.99
20.02.24
-
20.02.27
12.91%
16.07.24

robertinio 
20.02.24 100%
sell
Daiichi Sankyo Co Ltd

Start price
Target price
Perf. (%)
€30.99
20.02.24
-
20.02.27
12.91%
16.07.24

robertinio 
20.02.24 100%
sell
Novan Inc

Start price
Target price
Perf. (%)
€0.001
19.02.24
-
19.02.25
-
19.09.23

StockNews.com 
19.02.24 50%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€69.40
19.02.24
€85.00
30.09.25
3.75%
16.07.24

Could be very worthwhile Investment >20% year
BiotechBee 
19.02.24 70%
sell
Trupanion Inc.

Start price
Target price
Perf. (%)
€21.20
19.02.24
-
19.02.25
49.10%
16.07.24

Risky Investment
Lokrim 
19.02.24 20%
sell
Trevena Inc.

Start price
Target price
Perf. (%)
€0.51
18.02.24
-
18.02.25
-59.31%
16.07.24

StockNews.com 
18.02.24 50%
sell
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€0.70
18.02.24
-
18.02.25
-47.29%
18.06.24

ReynadJ 
18.02.24 0%
buy
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€0.70
18.02.24
-
18.02.25
-47.29%
18.06.24

collins 
18.02.24 0%
sell
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.22
18.02.24
-
18.02.25
-23.77%
16.07.24

goldmanns 
18.02.24 0%
sell
Coherus Bioscien.

Start price
Target price
Perf. (%)
€2.52
18.02.24
-
18.02.25
-40.36%
15.07.24

goldmanns 
18.02.24 0%
sell
Ocular Therapeutix Inc.

Start price
Target price
Perf. (%)
€7.19
18.02.24
-
18.02.25
6.98%
16.07.24

goldmanns 
18.02.24 0%
buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€8.30
17.02.24
€11.00
31.01.26
-31.30%
16.07.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.02.24 80%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€69.30
17.02.24
€76.07
17.02.25
3.90%
16.07.24

Mizuho 
17.02.24 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€26.60
17.02.24
€36.18
17.02.25
-64.37%
12.07.24

Mizuho 
17.02.24 50%
sell
Cara Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.54
17.02.24
-
17.02.25
-37.86%
16.07.24

StockNews.com 
17.02.24 50%
buy
Corcept Therapeutics Inc.

Start price
Target price
Perf. (%)
€21.00
17.02.24
-
17.02.25
45.57%
16.07.24

StockNews.com 
17.02.24 50%
sell
Durect Corp.

Start price
Target price
Perf. (%)
€0.37
17.02.24
-
17.02.25
-
05.12.22

StockNews.com 
17.02.24 50%
buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€12.69
17.02.24
-
17.02.25
52.03%
16.07.24

StockNews.com 
17.02.24 50%
buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€5.53
16.02.24
€11.13
16.02.25
-63.89%
16.07.24

UBS Group AG 
16.02.24 50%
buy
Atricure Inc.

Start price
Target price
Perf. (%)
€59.50
16.02.24
€53.79
16.02.25
-
30.09.21

UBS Group AG 
16.02.24 50%
buy
Atricure Inc.

Start price
Target price
Perf. (%)
€59.50
16.02.24
€38.96
16.02.25
-
30.09.21

Stifel Nicolaus 
16.02.24 50%